Paid Clinical Trials in East Brunswick, NJ
As of August 2026, 58 paid clinical trials are recruiting in East Brunswick, New Jersey. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
East Brunswick offers studies at sites including Astera Cancer Care for conditions such as Non-Small Cell Lung Cancer, Breast Cancer, Colorectal Cancer, Non-small Cell Lung Cancer (NSCLC). Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in East Brunswick
Trials by drug in East Brunswick
Filter results
Newly added in East Brunswick
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
DBC-664 in Adult Patients With Solid Tumors
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
57 clinical trials
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
SLV-154 Treatment of Advanced Cancers
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia
Study of GS-2426 in Participants With Advanced Solid Tumors
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer
A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors
Top Research Study Locations in East Brunswick
Researchers run research studies in East Brunswick, NJ at 16 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Astera Cancer Care | Colorectal Neoplasms, Multiple Myeloma, Non-small Cell Lung Cancer | 20 |
| START New Jersey | Prostatic Neoplasms, Advanced or Metastatic Solid Tumor, Castration-Resistant Prostate Cancer | 12 |
| Astera Cancer Care East Brunswick | Breast Cancer, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, HR+/HER2- Breast Cancer | 4 |
| Astera Cancer Care | Non Small Cell Lung Carcinoma, Non-Small Cell Lung Cancer, Colorectal Cancer | 4 |
| START Astera, LLC | Adenocarcinoma of Esophagus, Advanced Solid Tumors, Biliary Tract Carcinoma | 3 |
| Astera Cancer Care - 1128 | Non Small Cell Lung Cancer | 1 |
| Astera Cancer Care - East Brunswick | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Astera Cancer Center | Prostate Cancer | 1 |
| East Brunswick Surgery Center | Lumbar Spinal Stenosis | 1 |
| Exelixis Clinical | Clear Cell Renal Cell Carcinoma (ccRCC), Colorectal Cancer (CRC), Drug-Drug Interaction (DDI) | 1 |
| GSK Investigational Site | Neoplasms, Prostate | 1 |
| RWJ Cardiac Rehab at East Brunswick | Anxiety, Cardiac Rehabilitation, Exercise Sensitivity | 1 |
| RWJ Endosurgical Center | Lumbar Spinal Stenosis | 1 |
| Regional Cancer Care Associates LLC | Triple Negative Breast Cancer | 1 |
| START, Astera | Breast Cancer, Colo-rectal Cancer, Lung Cancer (Non-Small Cell) | 1 |
| Titan Health Partners Llc Dba Astera Cancer Care | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 1 |
Active & Upcoming Studies in East Brunswick (2026)
Recruiting trials in East Brunswick grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (41 active studies)
- A Study of APG-3288 in Relapsed/Refractory Blood Cancers · Phase 1 · Ascentage Pharma Group Inc.
- A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer · Phase 2 · Verastem, Inc.
Mental health & behavior (1 active study)
- Behavioral Exposure for Introceptive Tolerance RCT · Rutgers, The State University of New Jersey
Cardiovascular (1 active study)
- Behavioral Exposure for Introceptive Tolerance RCT · Rutgers, The State University of New Jersey
Common conditions studied in East Brunswick
- Non-Small Cell Lung Cancer (4 active studies)
- Breast Cancer (3 active studies)
- Colorectal Cancer (3 active studies)
- Non-small Cell Lung Cancer (NSCLC) (3 active studies)
- Colorectal Neoplasms (2 active studies)
- Gastric Adenocarcinoma (2 active studies)
Leading research sponsors in East Brunswick
- Janssen Research & Development, LLC
- AbbVie
- AstraZeneca
- Hoffmann-La Roche
- Verastem, Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in East Brunswick?
There are approximately 58 recruiting clinical trials in East Brunswick, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in East Brunswick pay participants?
Most recruiting trials in East Brunswick compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in East Brunswick?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in East Brunswick?
The most common conditions under active study in East Brunswick include Non-Small Cell Lung Cancer (4), Breast Cancer (3), Colorectal Cancer (3), Non-small Cell Lung Cancer (NSCLC) (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in East Brunswick?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in East Brunswick on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in East Brunswick?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in East Brunswick?
Recruiting research sites in East Brunswick include Astera Cancer Care, START New Jersey, Astera Cancer Care East Brunswick, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in East Brunswick right now?
The largest active categories in East Brunswick are Cancer & tumors (41), Mental health & behavior (1), Cardiovascular (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.